|
|
CAD software company and Japan National Cancer Center initiate colon and lung clinical studies
(Science Letter Via Thomson Dialog NewsEdge)
Medicsight Inc.'s (MGT) majority owned subsidiary, Medicsight KK, announced that it will initiate eight Japan clinical studies focusing on lung and colon cancer, jointly sponsored by the Japan National Cancer Center under the leadership of Professor N. Moriyama, director of the cancer screening technology division, National Cancer Center.
These clinical studies represent a major step forward in the company's plans to determine the performance of its unique ColonCAD and LungCAD software for Japanese patient groups.
"Medicsight is committed to ensuring our software is compatible with Japanese populations and is easy for Japanese radiologists to utilize. These studies with Japan National Cancer Center will help us demonstrate Medicsight's commitment to the Japanese radiological community and further add to its reputation as a global leader in CAD and medical imaging analysis," said David Sumner, Medicsight Asia CEO.
Sumner continued, "This series of trials will concentrate on showing how CAD can benefit radiologists in interpreting time consuming and difficult to read studies such as CT colonography and identifying lesions in the lung, such as nodules. It is the first time that such a series has taken place in Japan and we believe that it will further drive the adoption of CAD as being essential when reading these types of study."
Medicsight's CAD tools are designed to be seamlessly integrated into either 3D workstations or PACS and assist radiologists in the identification of potentially fatal lesions found in the lung and polyps found in the colon. By utilizing a concurrent-read approach Medicsight CAD allows radiologists to review the original images simultaneously with regions of interest generated by CAD. There is already evidence that demonstrates that using a concurrent-read paradigm improves radiologist workflow and productivity.
Medicsight is a developer of enterprise computer-aided detection (CAD) software for the medical imaging market.
This article was prepared by Science Letter editors from staff and other reports. Copyright 2006, Science Letter via NewsRx.com.
[ Back To TMCnet.com's Homepage ]
|
|
|
|
TMCnet LOGIN
Webinars
